Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Boyce Sarah, Director. Director active across 5 companies, notably Berkeley Lights, Inc.. Cumulatively, 38 reports have been recorded. Breakdown: 1 buy · 7 sells. Total volume traded: €3m. History available since 14 May 2021. The latest transaction was disclosed on 21 January 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Boyce Sarah
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
900 shares@ US$1.240.0% of flowCommon StockSEC:0001209191-23-007092:0
25 of 38 declarations
About Boyce Sarah
Boyce Sarah is Administrateur. She has filed 38 disclosures in total. Across the 38 sampled filings, the recent activity spans 2016-01-04 to 2026-02-27, with EUR 57,135 of buys and EUR 2,991,339 of sells, and the most frequent transaction type is Levée d'options. Her listed companies are Avidity Biosciences, Inc., where she is President and CEO, OmniAb, Inc., where she is Director, Ligand Pharmaceuticals INC, Ionis Pharmaceuticals INC, where she is Chief Business Officer, and Berkeley Lights, Inc., where she is Director.